Navigation Links
CardioWise™ Welcomes Geoffrey Dalbow as Chief Technology Officer
Date:3/15/2013

Fayetteville, AR (PRWEB) March 15, 2013

Geoffrey Dalbow has recently joined Cardiowise, Inc. as Chief Technology Officer. His background includes substantial leadership experience in the highly competitive area of medical technology. Through the application and optimization of emerging imaging technologies, he has delivered solutions that improved health care quality, safety and efficiencies, while reducing the cost of care. During his career, Mr. Dalbow has directed multiple research and development efforts delivering a broad range of products and solutions to improve healthcare. He managed and secured more than 80 patents for R2 Technology in the area of Computer-Aided Detection technology. His business experience is international in scope and includes India, China and the Middle East as well as South America.

Mr. Dalbow comes to CardioWise from CMS, Roper Industries where he was recently employed as the CTO and Director of Business Development. Prior to Roper, Geoffrey was the Director of Research and Development for Philips Medical Systems. Previous to that, Dalbow and a team of technology experts established R2 Technology, where he directed the research and development of medical solutions for computer-aided detection and diagnosis of cancer. In only three years, in his position as CTO, the company was taken from startup to market share leader and was successfully sold. Prior to R2 Technologies, Mr. Dalbow held several leadership positions with Varian Medical Systems. His wealth of imaging and product development expertise provides Cardiowise with the leadership needed to build the company’s innovative development and growth platform.

Mr. Dalbow received his Bachelor of Science from Carnegie Mellon University and completed numerous courses towards his Ph.D. in Medical Physics at the University of Pittsburgh. He has held management positions in several companies on the Forbes Best Managed Companies Top 100 List. Mr. Dalbow received the Company Leadership Award from Medical Imaging Magazine, presented a white paper to federal governing bodies, and has had articles published in industry trade magazines.

In his address at the World Health Organization (WHO) conference in Paris, Mr. Dalbow gave the presentation “Device Improvements to Reduce the Number of Under-Doses and Over-Doses and Misaligned Exposures from Therapeutic Radiation.” He has spoken at an FDA annual meeting on Meeting Standardization of Treatment Prescriptions for Oncology, as well as contributed to Computer Assisted Radiology and Surgery white papers on Just in Time Health Care. Dalbow has also managed multiple FDA submissions, including both 501k and PMA submissions. He remains engaged in emerging issues in health care, is dedicated to reducing costs through innovation, and is an industry chair for The Medical Imaging & Technology Alliance (MITA).

CardioWise™ is commercializing patent-pending, non-invasive Cardiac Magnetic Resonance Imaging (cMRI) analysis software that produces a quantified 3D image model of the human heart, called Multiparametric Strain (MPS™) heart analysis. CardioWise heart analysis software combined with cardiac MRI is a single diagnostic test that is able to provide quantitative analysis of the myocardium, arteries and valves with an unprecedented level of detail. It has the opportunity to become the new gold standard of care for heart health analysis. CardioWise™ is a VIC Technology Venture Development™ portfolio company.

Read the full story at http://www.prweb.com/releases/2013/3/prweb10535481.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Cepheid Welcomes Senior Vice President of Human Resources
2. The 14th Annual LOréal-Unesco Awards or Women on Science: From March 26 to March 29, Paris Welcomes and Honours Tomorrows Scientific Talents
3. Agendia Welcomes Dr. Mark Gittleman to Expanding Medical Advisory Board
4. United States Rocket Academy Welcomes XCOR Aerospace to Texas
5. Chiltern Welcomes Drs. Dieter Seitz-Tutter And Alexandra Adams
6. Elsevier Welcomes New Editor-in-Chief for European Urology
7. Ariosa Diagnostics Welcomes New Board Member Michael A. Aicher
8. ABC Welcomes New Advisory Board Members
9. Arecor Appoints Dr. Sarah Howell as Chief Operating Officer
10. John Saltamartine to Lead Operations as VR Laboratories Chief Operating Officer
11. Ambit Biosciences Names Michael A. Martino President and Chief Executive Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/31/2016)... ... , ... Adimarket, a subsidiary of Global Stem Cells Group, Inc. ... EmCyte technology, and is expected to be available to physicians in July, 2016. The ... vascular fraction (SVF) in a closed environment. , Adipose derived stem cells (ASCs) are ...
(Date:5/31/2016)... ... 2016 , ... Doctors in Italy say mesothelioma patients with the highest levels ... levels. Surviving Mesothelioma has just posted an article on the new research. Click ... La Spezia, Italy tested the blood serum, tumors, and lung fluid of 45 ...
(Date:5/27/2016)... ... May 27, 2016 , ... PBI-Gordon Corporation is pleased to announce Dave ... In his 15-year career with PBI-Gordon, Dave has served in a wide variety of ... in the development and launch of many of PBI-Gordon’s most successful products. , “Dave ...
(Date:5/26/2016)... and READING, England , ... ( http://www.indegene.com ), a leading global provider of ... pharmaceutical and healthcare organisations and TranScrip ( http://www.transcrip-partners.com ... support throughout the product lifecycle, today announced the ... of IntraScience.      (Logo: http://photos.prnewswire.com/prnh/20141208/720248 ...
Breaking Biology Technology:
(Date:3/31/2016)... RATON, Florida , March 31, 2016 ... LEGX ) ("LegacyXChange" or the "Company") ... for potential users of its soon to be launched ... video ( https://www.youtube.com/channel/UCyTLBzmZogV1y2D6bDkBX5g ) will also provide ... the use of DNA technology to an industry that ...
(Date:3/22/2016)... PROVO and SANDY, Utah ... Ontario (NSO), which operates the highest sample volume laboratory ... and Tute Genomics and UNIConnect, leaders in clinical sequencing ... announced the launch of a project to establish the ... panel. NSO has been contracted by ...
(Date:3/15/2016)... , March 15, 2016 Yissum ... , the technology-transfer company of the Hebrew University, announced ... of remote sensing technology of various human biological indicators. ... raising $2.0 million from private investors. ... based on the detection of electromagnetic emissions from sweat ...
Breaking Biology News(10 mins):